MyFinsight
Home
Blog
About
Back
Income Statement
Lantern Pharma Inc. (LTRN)
Lantern Pharma Inc. (LTRN)
source: myfinsight.com
Net loss
-$7,072,124
(-63.29%↓ Y/Y)
Interest income
$30,079
(-73.79%↓ Y/Y)
Other income, net
$14,926
(-92.76%↓ Y/Y)
Loss from operations
-$3,508,090
(24.59%↑ Y/Y)
Change in fair value of
warrant liability
$2,127,379
Warrant issuance costs
$755,233
Loss on issuance of
warrants
$726,427
Total operating
expenses
$3,508,090
(-24.59%↓ Y/Y)
Research and development
$1,790,859
(-41.64%↓ Y/Y)
General and
administrative
$1,717,231
(8.44%↑ Y/Y)
Back